CorMedix Inc expected to post a loss of 24 cents a share - Earnings Preview

CorMedix

04/08/2023 19:31

* CorMedix Inc  CRMD.OQ   CRMD.O  is expected to show a fall
in
quarterly revenue when it reports  results on August 8. 
    * 
    * ​Refinitiv's mean analyst estimate for CorMedix Inc is for
a
loss of 24 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for CorMedix
Inc is
$18​, above​ its last closing price of $4.22. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.20       -0.20      -0.24     Missed  -20
 Dec. 31 2023              -0.19      -0.20     Missed  -7
 Sep. 30 2022  -0.22       -0.23      -0.17     Beat    25.5​
 Jun. 30 2022  -0.20       -0.21      -0.19     Beat    8.1
 ​​Mar.        -0.22       -0.22      -0.18     Beat    18.2
 31 2022                                                
 Dec. 31 2021              -0.23      -0.20     Beat    14.3​
 Sep. 30 2021  -0.17       -0.18      -0.22     Missed  -24.5
 Jun. 30 2021  -0.19       -0.17      -0.12     Beat    30.4
 This summary was machine generated August 4 at 18:31 GMT.  All
figures in US dollars  unless otherwise stated